16.5 h (canrenone) | ~45 min (plasma) | | Renal excretion | Metabolites | Free amino acid + conjugates | | P-glycoprotein substrate | No confirmed interaction | Not applicable | Because glycine does not inhibit or induce CYP3A4, it is very unlikely to raise or lower spironolactone plasma concentrations
Ahmad SB, Ali A, Bilal M, Rashid SM, Wani AB, Bhat RR, et al
The article frames access and cost as legitimate decision factors and says compounded options may reduce financial barriers if your provider determines oral semaglutide is medically appropriate
According to the American Diabetes Association, in 2021, the prevalence of diabetes in the US was 11.6%, affecting 38.4 million Americans
Impact of metabolic syndrome on neuroinflammation and the bloodbrain barrier
C., Meng, Y., Bai, H., Shen, D